Director, Data Quality, Metadata and Semantic Standards Lead
GSK
Summary
The Director, Data Quality, Metadata and Semantic Standards Lead plays a pivotal role in strengthening GSK’s data governance maturity by giving data stewards and domains the data quality, metadata and semantic standards, tools and support needed to manage and reuse data with confidence and consistency.
Job description
As the capability product owner for data quality, metadata and semantic standards, this role provides strategic and technical leadership to design a cohesive and scalable framework that equips stewards across R&D to apply centrally defined governance standards, safeguard data quality and drive responsible reuse.
Key Responsibilities
- Define and communicate a vision for data quality, metadata and semantic standards as a product.
- Develop and own a data quality and metadata roadmap.
- Design and deliver the data quality framework and monitoring.
- Champion user-centric design and experience.
- Prioritise and manage the standards and tooling backlog.
- Foster a data quality and metadata community of practice.
- Measure, maximise and communicate value delivery.
- Lead the adoption of R&D-wide metadata, catalogue and semantic standards.
- Lead the governance tooling roadmap with data platform and IT teams.
- Ensure compliance, risk management and escalation.
- Continuously scan for innovation and best practice.
Requirements
- Bachelor’s or Master’s degree in Computer Science, Data Management, Mathematics, Statistics, Biostatistics, or a related field.
- Excellent communication and stakeholder engagement abilities.
- Strong leadership, team management, and stakeholder engagement skills.
- Broad experience in clinical development processes and R&D data lifecycle within the biotech or pharmaceutical industry.
- Experience of data quality, metadata and catalogue management within governance operating models.
- Working knowledge of semantic standards such as ontologies, CDISC SDTM/ADaM, ISO IDMP, controlled terminology and FAIR principles.
- Experience in data governance, data quality and metadata management within a complex, regulated environment.
- Demonstrated ability to design and deliver data quality and metadata solutions, including standards, tooling, and continuous improvement initiatives.
- Track record of collaborating with cross-functional teams to embed data quality and metadata practices into workflows.
- Strong background in data governance, policy development, standards management, metadata management, interoperability standards, data lineage, and data quality frameworks.
- Demonstrated ability to lead complex governance programmes, modernise policies, and operationalise compliance in partnership with technical and scientific teams.
Benefits
- Health care
- Insurance benefits
- Retirement benefits
- Paid holidays
- Vacation
- Paid caregiver leave
- Paid parental leave
- Paid medical leave
- Annual bonus
- Share based long term incentive program
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.